Evidence map›Paper›PMID 40654765›Full record

ArticlebioRxiv : the preprint server for biology2025

Minimal Gene Signatures Enable High-Accuracy Prediction of Antibiotic Resistance in

Nabia Shahreen, Syed Ahsan Shahid, Mahfuze Subhani, Adil Al-Siyabi, Rajib Saha

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Nabia ShahreenDepartment of Chemical and Biomolecular Engineering, University of Nebraska-Lincoln.ORCID 0000-0002-6461-6184
Syed Ahsan ShahidNatural and Medical Sciences Research Center, University of Nizwa.
Mahfuze SubhaniSchool of Computing, University of Nebraska-Lincoln.
Adil Al-SiyabiNatural and Medical Sciences Research Center, University of Nizwa.
Rajib SahaDepartment of Chemical and Biomolecular Engineering, University of Nebraska-Lincoln.ORCID 0000-0002-2974-0243

Funding

A Predictive Modeling Framework to Dissect the Dynamic Immunometabolic Responses to Pathogenic infection and the Kinetic Reprogramming of Metabolism in Cancer Cell SystemR35GM143009 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI SAHA, RAJIB · 2021 to 2025
$1.8M
NIGMS NIH HHS R35 GM143009
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) in Pseudomonas aeruginosa poses a critical global health challenge, with current diagnostics relying on slow, culture-based methods. Here, we present a ML framework leveraging transcriptomic data to predict antibiotic resistance with high accuracy. We applied a genetic algorithm to 414 clinical isolates to identify minimal, highly predictive gene sets (~35-40 genes) distinguishing resistant from susceptible strains for meropenem, ciprofloxacin, tobramycin, and ceftazidime. Automated ML classifiers trained on these sets achieved accuracies of 96-99% on test data (F1 scores: 0.93-0.99), surpassing clinical deployment thresholds. Multiple distinct, non-overlapping gene subsets exhibited comparable performance, indicating that resistance acquisition broadly impacts the expression of diverse regulatory and metabolic genes. Comparison with known resistance markers from CARD and operon annotations revealed a substantial number of previously unannotated clusters, highlighting significant knowledge gaps in current AMR understanding. Mapping these genes onto independently modulated gene sets (iModulons) revealed transcriptional adaptations across diverse genetic regions. Overall, this study presents a streamlined machine-learning workflow for transcriptomic data and offers a pathway toward rapid diagnostics and personalized treatment strategies against AMR.

Identifiers

PMID40654765
PMCPMC12247665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.